TopGum Industries, a gummy supplement manufacturer, has acquired Island Abbey Nutritionals, a contract development and manufacturing organization (CDMO) specializing in gummy and lozenge supplements located on Prince Edward Island, Canada.

The transaction expands TopGum’s manufacturing and technological capabilities in North America and globally.

Island Abbey was founded in 2004, and operates a 65,000 square-foot facility featuring manufacturing technologies including starchless depositing, center-fill capabilities, and automated bottling and packaging lines, all in adherence to quality standards from FDA, NSF, GMP, SQF, and Health Canada.

The acquisition will enhance TopGum’s ability to serve North American customers through a supply chain spanning two continents.

“I want to extend my sincere congratulations to everyone who contributed to bringing this important transaction to a successful close,” said Eyal Shohat, CEO of TopGum. “This marks a significant step forward for TopGum as we expand our global footprint and capabilities. We look forward to working closely with the Island Abbey team to unlock new opportunities for innovation and growth.”

“On behalf of the entire Island Abbey team, I’m thrilled to officially join forces with TopGum,” said Dean Williams, CEO of Island Abbey. “We’re excited to bring our expertise, capabilities, and passion for product innovation into this new partnership. Together, we’re well-positioned to accelerate the next chapter of growth for our customers and employees alike.”